Document Submission
31/05/2021Circular/Notice to Shareholders
| PHARMANIAGA BERHAD |
| Subject | CIRCULAR TO SHAREHOLDERS IN RELATION TO THE (I) PROPOSED BONUS ISSUE OF UP TO 1,047,994,928 NEW ORDINARY SHARES IN PHARMANIAGA (''BONUS SHARES'') ON THE BASIS OF 4 BONUS SHARES FOR EVERY 1 EXISTING ORDINARY SHARE IN PHARMANIAGA HELD ON AN ENTITLEMENT DATE TO BE DETERMINED AND ANNOUNCED LATER (''PROPOSED BONUS ISSUE''); (II) PROPOSED AMENDMENTS TO THE BY-LAWS GOVERNING THE EXISTING SHARE ISSUANCE SCHEME OF PHARMANIAGA ("SCHEME") (''PROPOSED BY-LAWS AMENDMENT''); AND (III) PROPOSED ALLOCATION OF THE OPTIONS AND THE SHARE GRANTS UNDER THE SCHEME TO THE GROUP MANAGING DIRECTOR OF PHARMANIAGA AND NOTICE OF EXTRAORDINARY GENERAL MEETING |
Please refer attachment below.
Attachments |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 31 May 2021 |
| Category | Document Submission |
| Reference Number | DCS-31052021-00017 |
Related Announcements for PHARMA
| Date | Title |
|---|---|
| 29/04/2022 | Circular/Notice to Shareholders |
| 29/04/2022 | Annual Report & CG Report |
| 24/05/2021 | Annual Report & CG Report |
| 21/05/2021 | Circular/Notice to Shareholders |
| 19/06/2020 | Circular/Notice to Shareholders |
| 19/06/2020 | Annual Report & CG Report |
| 25/03/2019 | Circular/Notice to Shareholders |
| 25/03/2019 | Annual Report & CG Report |
| 13/03/2018 | Annual Report & CG Report |
| 13/03/2018 | Circular/Notice to Shareholders |